For patients
Belimumab
anti-BLyS, Benlysta
Are you a clinician? See the clinical version of this page.
The short versionBelimumab is a lupus medicine that may be continued in pregnancy if it is needed to keep your lupus controlled, based on shared decision-making, since the data are still limited. It is considered compatible with breastfeeding.
- The decision is a balance between controlling lupus and limited pregnancy data.
Through your pregnancy journey
Use if needed
Before pregnancy
May be continued if needed to control lupus while planning; discuss with your team.
Use if needed
First trimester
Used if needed to keep lupus controlled.
Use if needed
Second & third trimester
Used if needed to keep lupus controlled.
Continue
Breastfeeding
Considered compatible with breastfeeding.
Individualise
For fathers-to-be
For fathers-to-be, data are limited; discuss with your team.
iThis page helps you prepare a conversation with your care team. It does not replace individual medical advice. Always confirm your own plan with your rheumatology and pregnancy team.
!
When to call your team
- Do not stop or start belimumab without your team.
- Tell your baby's team which biologics you took in pregnancy.